You just read:

Aevi Genomic Medicine Announces Top-Line Results from Placebo-Controlled ASCEND Trial (Parts A & B) of AEVI-001 in Children with ADHD

News provided by

Aevi Genomic Medicine, Inc.

Jan 02, 2019, 16:30 ET